NCT03607149View on ClinicalTrials.gov

Pemetrexed in Maintenance in Patients With Impaired Renal Function, 2 Dose Calculation Strategies

PHASE4CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

April 6, 2017

Primary Completion Date

February 20, 2020

Study Completion Date

February 20, 2020

Conditions
Non-small Cell Lung Cancer
Interventions
DRUG

Pemetrexed

"standard arm : calculating the dose of pemetrexed according to body surface area~experimental arm: calculation of the dose of pemetrexed as a function of creatinine clearance (CrCLCG)"

Trial Locations (3)

21079

Centre Georges Francois Leclerc, Dijon

Centre Universitaire Hospitalier de Dijon, Dijon

71100

CH William Morey, Chalon-sur-Saône

All Listed Sponsors
lead

Centre Georges Francois Leclerc

OTHER

NCT03607149 - Pemetrexed in Maintenance in Patients With Impaired Renal Function, 2 Dose Calculation Strategies | Biotech Hunter | Biotech Hunter